{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:10:08Z","timestamp":1786122608472,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.prro.2026.06.013","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:29:40Z","timestamp":1783726180000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implementation of a Multidisciplinary Radiopharmaceutical Dosimetry Program: Key Practical Considerations and Challenges"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2048-5116","authenticated-orcid":false,"given":"Mustafa M.","family":"Basree","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Besemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor F.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Grudzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott B.","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan P.","family":"Bednarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lawless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve Y.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7635-7554","authenticated-orcid":false,"given":"John M.","family":"Floberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2026.06.013_bib0001","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00259-013-2609-2","article-title":"Nothing new under the nuclear sun: Towards 80 years of theranostics in nuclear medicine","volume":"41","author":"Verburg","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.prro.2026.06.013_bib0002","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2967\/jnumed.118.219352","article-title":"Dosimetry of 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: Correlations between pretherapeutic imaging and whole-body tumor dosimetry with treatment outcomes","volume":"60","author":"Violet","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2026.06.013_bib0003","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1007\/s00259-022-05786-w","article-title":"Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients","volume":"49","author":"Sundl\u00f6v","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.prro.2026.06.013_bib0004","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijrobp.2022.08.010","article-title":"A Primer on radiopharmaceutical therapy","volume":"115","author":"Salerno","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.06.013_bib0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2967\/jnumed.124.268903","article-title":"Dosimetry of [177Lu]Lu-DOTATATE in patients with advanced midgut neuroendocrine tumors: Results from a substudy of the phase III NETTER-1 trial","volume":"66","author":"Bodei","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2026.06.013_bib0006","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.prro.2024.12.005","article-title":"Radiopharmaceutical and radioembolization therapy: Clinical guidance for medical physicists in radiation oncology","volume":"15","author":"Polignani","year":"2025","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2026.06.013_bib0007","first-page":"451","article-title":"Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: Largest safe dose using a risk-adapted approach","volume":"44","author":"Dorn","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2026.06.013_bib0008","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1677\/ERC-09-0076","article-title":"Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma","volume":"16","author":"H\u00e4nscheid","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.prro.2026.06.013_bib0009","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","article-title":"Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): A randomised, multicentre, open-label phase 2 trial","volume":"6","author":"Garin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.prro.2026.06.013_bib0010","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): An open-label randomised controlled phase 3 trial","volume":"18","author":"Vilgrain","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2026.06.013_bib0011","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1200\/JCO.2015.66.1181","article-title":"SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer","volume":"34","author":"van Hazel","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2026.06.013_bib0012","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1148\/radiol.2020191606","article-title":"Relationship of tumor radiation-absorbed dose to survival and response in hepatocellular carcinoma treated with transarterial radioembolization with 90Y in the SARAH study","volume":"296","author":"Hermann","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.prro.2026.06.013_bib0013","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12876-022-02204-1","article-title":"A prospective, multicenter, open-label, single-arm clinical trial design to evaluate the safety and efficacy of 90Y resin microspheres for the treatment of unresectable HCC: The DOORwaY90 (Duration Of Objective Response with arterial Ytrrium-90) study","volume":"22","author":"Mahvash","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.prro.2026.06.013_bib0014","unstructured":"FDA. Summary of Safety and Effectiveness (SSED) Template. Accessed February 15, 2026.https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf\/P990065S014B.pdf"},{"key":"10.1016\/j.prro.2026.06.013_bib0015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00259-024-06863-y","article-title":"The LUTADOSE trial: Tumour dosimetry after the first administration predicts progression free survival in gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu]Lu-DOTATATE","volume":"52","author":"Maccauro","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.prro.2026.06.013_bib0016","doi-asserted-by":"crossref","first-page":"900","DOI":"10.2967\/jnumed.124.269389","article-title":"Multicycle dosimetric behavior and dose-effect relationships in [177Lu]Lu-DOTATATE peptide receptor radionuclide therapy","volume":"66","author":"Kayal","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2026.06.013_bib0017","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.prro.2025.03.006","article-title":"Quality and safety considerations for radiopharmaceutical therapy in the radiation oncology environment: An ASTRO safety white paper","volume":"15","author":"Zoberi","year":"2025","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2026.06.013_bib0018","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2967\/jnumed.108.056036","article-title":"MIRD pamphlet No. 21: A generalized schema for radiopharmaceutical dosimetry\u2013standardization of nomenclature","volume":"50","author":"Bolch","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2026.06.013_bib0019","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2967\/jnumed.108.056705","article-title":"Effect of patient morphology on dosimetric calculations for internal irradiation as assessed by comparisons of Monte Carlo versus conventional methodologies","volume":"50","author":"Divoli","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2026.06.013_bib0020","first-page":"9","article-title":"A schema for absorbed-dose calculations for biologically-distributed radionuclides","volume":"Suppl 1","author":"Loeevinger","year":"1968","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2026.06.013_bib0021","first-page":"1023","article-title":"OLINDA\/EXM: The second-generation personal computer software for internal dose assessment in nuclear medicine","volume":"46","author":"Stabin","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2026.06.013_bib0022","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.2967\/jnumed.111.100123","article-title":"MIRD pamphlet No. 23: Quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy","volume":"53","author":"Dewaraja","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2026.06.013_bib0023","doi-asserted-by":"crossref","DOI":"10.1002\/mp.18076","article-title":"Validation of the collapsed-cone superposition for whole-body patient-specific dosimetry in [177Lu]Lu-PSMA-617 radionuclide therapy","volume":"52","author":"Terro","year":"2025","journal-title":"Med Phys"},{"key":"10.1016\/j.prro.2026.06.013_bib0024","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/jpm12020205","article-title":"Personalized dosimetry in targeted radiation therapy: A Look to methods, tools and critical aspects","volume":"12","author":"Danieli","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.prro.2026.06.013_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2025.104965","article-title":"Methodology for comparing absorbed dose rate calculation algorithms in molecular radiotherapy dosimetry","volume":"133","author":"Fragoso-Negr\u00edn","year":"2025","journal-title":"Phys Med"},{"key":"10.1016\/j.prro.2026.06.013_bib0026","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2967\/jnumed.117.201095","article-title":"Whole-body voxel-based personalized dosimetry: The multiple voxel S-value approach for heterogeneous media with nonuniform activity distributions","volume":"59","author":"Lee","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2026.06.013_bib0027","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1002\/mp.12256","article-title":"Use of image registration and fusion algorithms and techniques in radiotherapy: Report of the AAPM Radiation Therapy Committee Task Group No. 132","volume":"44","author":"Brock","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.prro.2026.06.013_bib0028","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s00259-009-1347-y","article-title":"Routine quality control recommendations for nuclear medicine instrumentation","volume":"37","author":"Busemann Sokole","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.prro.2026.06.013_bib0029","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2967\/jnumed.122.264594","article-title":"Toward single-time-point image-based dosimetry of 177Lu-PSMA-617 therapy","volume":"64","author":"Brosch-Lenz","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2026.06.013_bib0030","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2967\/jnumed.123.266871","article-title":"Impact of the reference multiple-time-point dosimetry protocol on the validity of single-time-point dosimetry for [177Lu]Lu-PSMA-I&T therapy","volume":"65","author":"Resch","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2026.06.013_bib0031","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00259-024-07010-3","article-title":"Influence of dosimetry accuracy on the correlation with treatment outcome in a preliminary PSMA radiopharmaceutical therapy study","volume":"52","author":"Hu","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.prro.2026.06.013_bib0032","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2967\/jnumed.123.265448","article-title":"Renal and multiorgan safety of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer in the VISION dosimetry substudy","volume":"65","author":"Herrmann","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2026.06.013_bib0033","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.2967\/jnumed.121.262752","article-title":"Reimbursement approaches for radiopharmaceutical dosimetry: Current status and future opportunities","volume":"62","author":"Graves","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2026.06.013_bib0034","series-title":"AAPM","article-title":"Standardized immobilization and setup procedure improves accuracy of multi-time point SPECT\/CT image registration for radiopharmaceutical therapy (RPT) dosimetry","author":"Khoudary","year":"2025"},{"key":"10.1016\/j.prro.2026.06.013_bib0035","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2967\/jnumed.122.265094","article-title":"An international study of factors affecting variability of dosimetry calculations, part 2: Overall variabilities in absorbed dose","volume":"64","author":"Brosch-Lenz","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2026.06.013_bib0036","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2967\/jnumed.122.265340","article-title":"Quality assurance considerations in radiopharmaceutical therapy dosimetry using PLANETDose: An international atomic energy agency study","volume":"65","author":"Kayal","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2026.06.013_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182888","article-title":"Quantitative accuracy of 177Lu SPECT imaging for molecular radiotherapy","volume":"12","author":"Mezzenga","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.prro.2026.06.013_bib0038","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2967\/jnumed.118.211094","article-title":"Characterization of noise and resolution for quantitative 177Lu SPECT\/CT with xSPECT quant","volume":"60","author":"Tran-Gia","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2026.06.013_bib0039","doi-asserted-by":"crossref","first-page":"N539","DOI":"10.1088\/0031-9155\/52\/24\/N01","article-title":"The importance of the accuracy of image registration of SPECT images for 3D targeted radionuclide therapy dosimetry","volume":"52","author":"Papavasileiou","year":"2007","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.prro.2026.06.013_bib0041","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s11307-026-02103-x","article-title":"Estimation and correction of the partial volume effect using personalized phantoms of lymph node metastases in lutetium 177 SPECT\/CT dosimetry","volume":"28","author":"Hinz","year":"2026","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.prro.2026.06.013_bib0042","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2967\/jnumed.107.048132","article-title":"Uncertainties in internal dose calculations for radiopharmaceuticals","volume":"49","author":"Stabin","year":"2008","journal-title":"J Nucl Med"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026002092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026002092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T11:25:30Z","timestamp":1786101930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850026002092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"alternative-id":["S1879850026002092"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2026.06.013","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementation of a Multidisciplinary Radiopharmaceutical Dosimetry Program: Key Practical Considerations and Challenges","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2026.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}